Successful PhD Defense on Personalized Medicine in Cystic Fibrosis

On October 31st, Steffie Vonk successfully defended her PhD thesis titled “Towards Personalized Medicine in Cystic Fibrosis. Focusing on Clinical Pharmacology of CFTR modulators.”

Her research contributes to the growing field of personalized medicine, with a specific focus on optimizing the clinical pharmacology of CFTR modulators for patients with cystic fibrosis.

Close the survey
Geef uw mening over de website, of vertel ons hoe wij onze website kunnen verbeteren.
The following privacy and terms of service links belong to Google's reCAPTCHA plugin.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.